相似文献
1
Ebola virus and persistent chronic infection: when does replication cease?埃博拉病毒与持续性慢性感染：复制何时停止？
Ann Transl Med. 2018 Nov;6(Suppl 1):S39. doi: 10.21037/atm.2018.09.60.
2
Persistent infection with ebola virus under conditions of partial immunity.在部分免疫条件下埃博拉病毒的持续感染。
J Virol. 2004 Jan;78(2):958-67. doi: 10.1128/jvi.78.2.958-967.2004.
3
Tolerance and Persistence of Ebola Virus in Primary Cells from , a Potential Ebola Virus Reservoir.从一种潜在的埃博拉病毒储存库——中，发现了埃博拉病毒在原代细胞中的耐受性和持久性。
Viruses. 2021 Oct 29;13(11):2186. doi: 10.3390/v13112186.
4
Ebola virus defective interfering particles and persistent infection.埃博拉病毒缺陷干扰颗粒与持续性感染
Virology. 1999 Sep 15;262(1):114-28. doi: 10.1006/viro.1999.9915.
5
Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication.抗体的被动转移可保护免疫功能正常和免疫缺陷的小鼠免受致死性埃博拉病毒感染，而不会完全抑制病毒复制。
J Virol. 2001 May;75(10):4649-54. doi: 10.1128/JVI.75.10.4649-4654.2001.
6
Active Ebola Virus Replication and Heterogeneous Evolutionary Rates in EVD Survivors.埃博拉病毒幸存者体内的活跃复制和异质进化速率。
Cell Rep. 2018 Jan 30;22(5):1159-1168. doi: 10.1016/j.celrep.2018.01.008.
7
Inhibition of Ebola infection by anti-parasitic quinoline derivatives.抗寄生虫喹啉衍生物抑制埃博拉病毒感染。
F1000Res. 2020 Apr 17;9:268. doi: 10.12688/f1000research.22352.1. eCollection 2020.
8
A Rapid Screening Assay Identifies Monotherapy with Interferon-ß and Combination Therapies with Nucleoside Analogs as Effective Inhibitors of Ebola Virus.一种快速筛查检测法确定，单用β干扰素以及核苷类似物联合疗法是埃博拉病毒的有效抑制剂。
PLoS Negl Trop Dis. 2016 Jan 11;10(1):e0004364. doi: 10.1371/journal.pntd.0004364. eCollection 2016 Jan.
9
Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture.反向遗传学表明，埃博拉病毒糖蛋白的蛋白水解加工对于在细胞培养中的复制并非必不可少。
J Virol. 2002 Jan;76(1):406-10. doi: 10.1128/jvi.76.1.406-410.2002.
10
Linked Mutations in the Ebola Virus Polymerase Are Associated with Organ Specific Phenotypes.埃博拉病毒聚合酶中的连锁突变与器官特异性表型相关。
Microbiol Spectr. 2023 Mar 22;11(2):e0415422. doi: 10.1128/spectrum.04154-22.
引用本文的文献
1
Stress Granules in Infectious Disease: Cellular Principles and Dynamic Roles in Immunity and Organelles.传染病中的应激颗粒：细胞原理及其在免疫和细胞器中的动态作用
Int J Mol Sci. 2024 Dec 2;25(23):12950. doi: 10.3390/ijms252312950.
2
Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative.长新冠治疗试验：RECOVER 倡议干预工作组的行动呼吁。
Front Immunol. 2023 Mar 9;14:1129459. doi: 10.3389/fimmu.2023.1129459. eCollection 2023.
3
AAV-monoclonal antibody expression protects mice from Ebola virus without impeding the endogenous antibody response to heterologous challenge.腺相关病毒-单克隆抗体表达可保护小鼠免受埃博拉病毒感染，同时不阻碍其对异源攻击的内源性抗体反应。
Mol Ther Methods Clin Dev. 2022 Aug 12;26:505-518. doi: 10.1016/j.omtm.2022.08.003. eCollection 2022 Sep 8.
4
Increased Prevalence of Lassa Fever Virus-Positive Rodents and Diversity of Infected Species Found during Human Lassa Fever Epidemics in Nigeria.在尼日利亚人类拉沙热流行期间发现的拉沙热病毒阳性啮齿动物的流行率增加和感染物种的多样性。
Microbiol Spectr. 2022 Aug 31;10(4):e0036622. doi: 10.1128/spectrum.00366-22. Epub 2022 Aug 1.
5
Immune Privilege: The Microbiome and Uveitis.免疫赦免：微生物群与葡萄膜炎
Front Immunol. 2021 Jan 25;11:608377. doi: 10.3389/fimmu.2020.608377. eCollection 2020.
6
On the whereabouts of SARS-CoV-2 in the human body: A systematic review.关于 SARS-CoV-2 在人体中的去向：一项系统综述。
PLoS Pathog. 2020 Oct 30;16(10):e1009037. doi: 10.1371/journal.ppat.1009037. eCollection 2020 Oct.
7
Expression of microRNA in human retinal pigment epithelial cells following infection with Zaire ebolavirus.感染扎伊尔埃博拉病毒后人类视网膜色素上皮细胞中微小RNA的表达
BMC Res Notes. 2019 Oct 1;12(1):639. doi: 10.1186/s13104-019-4671-8.
本文引用的文献
1
How myeloid cells contribute to the pathogenesis of prominent emerging zoonotic diseases.髓系细胞如何促进新兴突出人畜共患病的发病机制。
J Gen Virol. 2018 Aug;99(8):953-969. doi: 10.1099/jgv.0.001024. Epub 2018 Jun 25.
2
Cytomegalovirus establishes a latent reservoir and triggers long-lasting inflammation in the eye.巨细胞病毒在眼部建立潜伏储库并引发持久的炎症。
PLoS Pathog. 2018 May 31;14(5):e1007040. doi: 10.1371/journal.ppat.1007040. eCollection 2018 May.
3
Ebolaviruses: New roles for old proteins.埃博拉病毒：老蛋白的新角色。
PLoS Negl Trop Dis. 2018 May 3;12(5):e0006349. doi: 10.1371/journal.pntd.0006349. eCollection 2018 May.
4
Active Ebola Virus Replication and Heterogeneous Evolutionary Rates in EVD Survivors.埃博拉病毒幸存者体内的活跃复制和异质进化速率。
Cell Rep. 2018 Jan 30;22(5):1159-1168. doi: 10.1016/j.celrep.2018.01.008.
5
An update on ocular complications of Ebola virus disease.埃博拉病毒病眼部并发症的最新情况。
Curr Opin Ophthalmol. 2017 Nov;28(6):600-606. doi: 10.1097/ICU.0000000000000426.
6
Identification and pathological characterization of persistent asymptomatic Ebola virus infection in rhesus monkeys.鉴定并分析恒河猴体内持续性无症状埃博拉病毒感染的病理特征。
Nat Microbiol. 2017 Jul 17;2:17113. doi: 10.1038/nmicrobiol.2017.113.
7
Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction.外泌体中的埃博拉病毒VP40可导致免疫细胞功能障碍。
Front Microbiol. 2016 Nov 7;7:1765. doi: 10.3389/fmicb.2016.01765. eCollection 2016.
8
Molecular mechanisms of Ebola pathogenesis.埃博拉病毒致病的分子机制。
J Leukoc Biol. 2016 Nov;100(5):889-904. doi: 10.1189/jlb.4RI0316-099RR. Epub 2016 Sep 1.
9
Human Cytomegalovirus Latency: Approaching the Gordian Knot.人类巨细胞病毒潜伏：接近戈尔迪之结。
Annu Rev Virol. 2016 Sep 29;3(1):333-357. doi: 10.1146/annurev-virology-110615-042422. Epub 2016 Aug 4.
10
Persistence of Ebola Virus in Ocular Fluid during Convalescence.埃博拉病毒在康复期眼液中的持续存在。
N Engl J Med. 2015 Jun 18;372(25):2423-7. doi: 10.1056/NEJMoa1500306. Epub 2015 May 7.
Zotero 插件